JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 13, Issue 4 (2021)
Iran J War Public Health 2021, 13(4): 235-238 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2021/09/4 | Accepted: 2021/10/4 | Published: 2022/01/24
Received: 2021/09/4 | Accepted: 2021/10/4 | Published: 2022/01/24
How to cite this article
Bdaiwi S, Abdul - Saheb R. Variation in the Outcome following Intralesional 5-FU in the Treatment of Various Forms of Cutaneous Warts in Iraqi Patients based on Clinical Presentation. Iran J War Public Health 2021; 13 (4) :235-238
URL: http://ijwph.ir/article-1-1032-en.html
URL: http://ijwph.ir/article-1-1032-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
S.A. Bdaiwi *1, R.H. Abdul - Saheb2
1- Lecturer/ dermatology specialist/ Department of Medicine, College of Medicine, University of Al- Qadisiyah, Iraq
2- Diwaniyah Teaching Hospital, Al-Qadisiyah, Iraq
2- Diwaniyah Teaching Hospital, Al-Qadisiyah, Iraq
Abstract (1411 Views)
Aims: The current study was conducted to see the safety and efficacy of intralesional 5-FU in treating cutaneous warty lesions in a sample of Iraqi patients.
Methods: This experimental study was conducted in patients with various warty skin lesions from August 2020 to August 2021. Sixty patients visited the dermatology unit at Aldiwaniyah teaching hospital, Iraq, and were selected for the study. The new solution containing 4mL of 50mg/mL 5-fluorouracil was injected strictly intralesionally till blanching of the lesion occurred. After two weeks of 5-fluorouracil injection, a black ecchymosed eschar developed, which was pared, and residual warts, if present, were injected a second time. The patients were followed up to 3 months and then quarterly up to 1 year. Persistence of wart after three months of the last injection was taken as a failure of treatment. The statistical analysis was done with the SPSS 16 and Excel 2007 using the Chi-square test.
Findings: The complete response to treatment was seen in 200 (80.0%), partial response was seen in 37 (14.8%), and no response was recorded in 13 (5.2%) of cases. There was no significant association between size of warty lesion and response to intralesional 5-FU (p=0.154); however, there was a significant association between type of warty lesion and response to intralesional 5-FU (p=0.046).
Conclusion: Intralesional 5-FU appears to be highly effective in treating cutaneous warts; however, the response is influenced by the type of skin lesion, being maximal with palmoplantar wart and least common with the skin lesion periungual lesions.
Methods: This experimental study was conducted in patients with various warty skin lesions from August 2020 to August 2021. Sixty patients visited the dermatology unit at Aldiwaniyah teaching hospital, Iraq, and were selected for the study. The new solution containing 4mL of 50mg/mL 5-fluorouracil was injected strictly intralesionally till blanching of the lesion occurred. After two weeks of 5-fluorouracil injection, a black ecchymosed eschar developed, which was pared, and residual warts, if present, were injected a second time. The patients were followed up to 3 months and then quarterly up to 1 year. Persistence of wart after three months of the last injection was taken as a failure of treatment. The statistical analysis was done with the SPSS 16 and Excel 2007 using the Chi-square test.
Findings: The complete response to treatment was seen in 200 (80.0%), partial response was seen in 37 (14.8%), and no response was recorded in 13 (5.2%) of cases. There was no significant association between size of warty lesion and response to intralesional 5-FU (p=0.154); however, there was a significant association between type of warty lesion and response to intralesional 5-FU (p=0.046).
Conclusion: Intralesional 5-FU appears to be highly effective in treating cutaneous warts; however, the response is influenced by the type of skin lesion, being maximal with palmoplantar wart and least common with the skin lesion periungual lesions.
Keywords:
References
1. Dall'oglio F, D'Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13(2):73-96. [Link] [DOI:10.2165/11594610-000000000-00000] [PMID]
2. Ringin SA. The effectiveness of cutaneous wart resolution with current treatment modalities. J Cutan Aesthet Surg. 2020;13(1):24-30. [Link]
3. Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British association of dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712. [Link] [DOI:10.1111/bjd.13310] [PMID]
4. Liu J, Li H, Yang F, Ren Y, Xia T, Zhao Z, et al. Epidemiology and clinical profile of cutaneous warts in Chinese college students: a cross-sectional and follow-up study. Sci Rep. 2018;8(1):15450. [Link] [DOI:10.1038/s41598-018-33511-x] [PMID] [PMCID]
5. Yamamah GA, Emam HM, Abdelhamid MF, Elsaie ML, Shehata H, Farid T, et al. Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt. Int J Dermatol. 2012;51(10):1180-5. [Link] [DOI:10.1111/j.1365-4632.2012.05475.x] [PMID]
6. Silverberg JI, Silverberg NB. The US prevalence of common warts in childhood: a population-based study. J Invest Dermatol. 2013;133(12):2788-90. [Link] [DOI:10.1038/jid.2013.226] [PMID]
7. Bruggink SC, Eekhof JAH, Egberts PF, van Blijswijk SCE, Assendelft WJJ, Gussekloo J. Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study. Ann Fam Med. 2013;11(5):437-41. [Link] [DOI:10.1370/afm.1508] [PMID] [PMCID]
8. Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;2012(9):CD001781. [Link] [DOI:10.1002/14651858.CD001781.pub3] [PMID] [PMCID]
9. Massing AM, Epstein WL. Natural history of warts: a two-year study. Arch Dermatol. 1963;87:306-10 [Link] [DOI:10.1001/archderm.1963.01590150022004] [PMID]
10. van der Werf E. Studies on the incidence and course of warts in school children. Ned Tijdschr Geneeskd. 1959;103(23):1204-8. [Dutch] [Link]
11. Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British schoolchildren. Br J Dermatol. 1993;128(5):504-11 [Link] [DOI:10.1111/j.1365-2133.1993.tb00226.x] [PMID]
12. Bruggink SC, Gussekloo J, de Koning MN, Feltkamp MC, Bavinck JN, Quint WG, et al. HPV type in plantar warts influences natural course and treatment response: secondary analysis of a randomised controlled trial. J Clin Virol. 2013;57(3):227-32. [Link] [DOI:10.1016/j.jcv.2013.02.021] [PMID]
13. Abd-Elazeim FM, Mohammed GF, Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J Dermatolog Treat. 2014;25(3):264-7. [Link] [DOI:10.3109/09546634.2013.768760] [PMID]
14. Isçimen A, Aydemir EH, Göksügür N, Engin B. Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo-controlled, single-blind randomized study. J Eur Acad Dermatol Venereol. 2004;18(4):455-8. [Link] [DOI:10.1111/j.1468-3083.2004.00984.x] [PMID]
15. Kannambal K, Kaviarasan PK, Prasad PVS, Poorana B, Balajiganesh J. Efficacy of intralesional 5-fluorouracil in recalcitrant warts a study at tertiary care centre. J Med Sci Clin Res. 2019;7:556-60. [Link] [DOI:10.18535/jmscr/v7i6.94]
16. Ghonemy S, Ibrahim Ali M, Ebrahim HM. The efficacy of microneedling alone vs its combination with 5-fluorouracil solution vs 5-fluorouracil intralesional injection in the treatment of plantar warts. Dermatol Ther. 2020;33(6):e14179. [Link] [DOI:10.1111/dth.14179] [PMID]
17. Konicke K, Olasz E. Successful treatment of recalcitrant plantar warts with bleomycin and microneedling. Dermatol Surg. 2016;42(8):1007-8. [Link] [DOI:10.1097/DSS.0000000000000738] [PMID]
18. Mahajan BB, Singla M. Evaluation of intralesional 5% 5-fluorouracil in resistant localized plaque psoriasis. Indian Dermatol Online J. 2014;5(3):287-90. [Link] [DOI:10.4103/2229-5178.137779] [PMID] [PMCID]
19. Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat. 2009;20(6):328-35. [Link] [DOI:10.3109/09546630902789326] [PMID]
20. Bunney MH. The treatment of plantar warts with 5-fluorouracil. Br J Dermatol 1973;89:96-7 [Link] [DOI:10.1111/j.1365-2133.1973.tb01926.x] [PMID]
21. Yazdanfar A, Farshchian M, Fereydoonnejad M, Farshchian M. Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: a prospective placebo-controlled, double-blind randomized trial. Dermatol Surg. 2008;34(5):656-9.
https://doi.org/10.1111/j.1524-4725.2007.34123.x [Link] [DOI:10.1097/00042728-200805000-00009] [PMID]
22. Gibbs S. The trials of treating warts. Indian J Dermatol Venereol Leprol. 2014;80:495-6. [Link] [DOI:10.4103/0378-6323.144142] [PMID]
23. Khozeimeh F, Jabbari Azad F, Mahboubi Oskouei Y, Jafari M, Tehranian S, Alizadehsani R, et al. Intralesional immunotherapy compared to cryotherapy in the treatment of warts. Int J Dermatol. 2017;56(4):474-8. [Link] [DOI:10.1111/ijd.13535] [PMID]
24. Srivastava A, Ghiya BC, Soni p, Dave H, Dhanwal A, Mehta RD. Efficacy of intralesional 5-fluorouracil in treatment of Palmo-plantar warts. Int J Med Res. 2016;2(3):60-3. [Link] [DOI:10.21276/ijmrp.2016.2.3.013]
25. Kenawi MZ, Sherine H, EL-Rahman SH, Salam OH. Efficacy of Intralesional 5-fluorouracil versus BCG vaccine in the treatment of warts. Egypt J Dermatol Androl. 2012;32:3-14. [Link]